UniProt/SwissProt ID: | ITB3_HUMAN |
Description: | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) [Source:HGNC Symbol;Acc:6156] |
Location: | chr17 q21.32 |
Node attribute: | substrate |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
T777 | LYKEAtSTFTN | Integrin_b_cyt | PhosphoSitePlus |
T779 | KEATStFTNIT | AKT1(PKB | RegPhos; SysPTM |
Y785 | FTNITyR | SRC | HPRD; phosphoELM; SysPTM |
Y773 | ANNPLyKEATS | Integrin_b_cyt | PhosphoSitePlus; SysPTM |
T784 | TFTNItYRGT_ | Integrin_b_cyt | PhosphoSitePlus |
T779 | KEATStFTNIT | PDPK1 | HPRD; SysPTM |
T779 | KEATStFTNIT | AKT1 | HPRD; RegPhos; SysPTM |
T227 | LTDQVtRFNEE | Integrin_beta | PhosphoSitePlus |
Y773 | ANNPLyKEATS | SRC | HPRD; phosphoELM; RegPhos; SysPTM |
Y773 | ANNPLyKEATS | phosphoELM; RegPhos; SysPTM | |
T779 | KEATStFTNIT | HPRD; RegPhos; SysPTM | |
T208 | CYDMKtTCLPM | Integrin_beta | PhosphoSitePlus |
Y785 | FTNITyRGT__ | Integrin_b_cyt | PhosphoSitePlus; SysPTM |
S439 | QEKEKsFTIKP | Integrin_beta | PhosphoSitePlus |
T779 | KEATStFTNIT | PDK1 | HPRD; RegPhos; SysPTM |
Y773 | ANNPLyKEATS | Src | RegPhos; SysPTM |
Y785 | FTNITyR | SYK | phosphoELM; SysPTM |
Y785 | FTNITyR | phosphoELM; SysPTM | |
T779 | KEATStFTNIT | PDK-1 | phosphoELM; SysPTM |
Y660 | NTCNRyCRDEI | Integrin_B_tail | PhosphoSitePlus |
T779 | KEATStFTNIT | Integrin_b_cyt | PhosphoSitePlus; SysPTM |
Y785 | FTNITyRGT | Syk | RegPhos; SysPTM |
Y785 | FTNITyRGT | SRC | RegPhos; SysPTM |
Y785 | FTNITyRGT | Src | RegPhos; SysPTM |
Y773 | ANNPLyKEATS | Syk | RegPhos; SysPTM |
T777 | LYKEAtSTFTN | PDK-1 | phosphoELM |
T777 | LYKEAtSTFTN | PDK1 | RegPhos |
S778 | YKEATsTFTNI | Integrin_b_cyt | PhosphoSitePlus |
Y785 | FTNITyRGT | RegPhos; SysPTM | |
T779 | KEATStFTNIT | PDHK1 | RegPhos; SysPTM |
T441 | KEKSFtIKPVG | Integrin_beta | PhosphoSitePlus |
Dephosphorylation site |
ITB3_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000262017 | T629I | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000262017 | G484E | TCGA | Neoplasms by Histologic Type | 21720365, 18772890 |
ENSP00000262017 | R378C | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000262017 | Y190C | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000262017 | A776V | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000262017 | A776V | TCGA | Neoplasms by Histologic Type | 21720365, 18772890 |
ENSP00000262017 | E232* | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000262017 | R378C | TCGA | Neoplasms by Histologic Type | 21720365, 18772890 |
ENSP00000262017 | V109G | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000262017 | T629I | TCGA | Neoplasms by Histologic Type | 21720365, 18772890 |
ENSP00000262017 | G484E | COSMIC | Central Nervous System Neoplasms | 18772890 |
Differential expressed protein |
Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
---|---|---|---|---|---|---|
ENSP00000262017 | Neoplasms by Histologic Type | Treatment (none vs. SB203580 treatment 3 hour) | cell line | Down | 0.59 | 15169874 |
ENSP00000262017 | Neoplasms by Histologic Type | Treatment (none vs. SB203580 treatment 21 hour) | cell line | Down | 0.4 | 15169874 |
Hyperphosphorylation site |
ITB3_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
SRC_HUMAN | ITB3_HUMAN | kinase -> substrate | RegPhos |
AKT1_HUMAN | ITB3_HUMAN | kinase -> substrate | HPRD; RegPhos |
PDK1_HUMAN | ITB3_HUMAN | kinase -> substrate | RegPhos |
ZAGL2_HUMAN | ITB3_HUMAN | kinase -> substrate | RegPhos |
KSYK_HUMAN | ITB3_HUMAN | kinase -> substrate | Robert H Newman (2013) |
PDPK1_HUMAN | ITB3_HUMAN | kinase -> substrate | RegPhos |
Function Annotation |
KEGG Pathway |
KEGG ID | Pathway |
---|---|
hsa05414 | Dilated cardiomyopathy |
hsa04380 | Osteoclast differentiation |
hsa05410 | Hypertrophic cardiomyopathy (HCM) |
hsa04640 | Hematopoietic cell lineage |
hsa04145 | Phagosome |
hsa04512 | ECM-receptor interaction |
hsa05412 | Arrhythmogenic right ventricular cardiomyopathy (A |
hsa04510 | Focal adhesion |
hsa04810 | Regulation of actin cytoskeleton |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0031092 | platelet alpha granule membrane | TAS | cellular_component |
GO:0050731 | positive regulation of peptidyl-tyrosine phosphory | IMP | biological_process |
GO:0016020 | membrane | IEA | cellular_component |
GO:0005634 | nucleus | IDA | cellular_component |
GO:0008305 | integrin complex | IDA | cellular_component |
GO:0043184 | vascular endothelial growth factor receptor 2 bind | IPI | molecular_function |
GO:0032369 | negative regulation of lipid transport | IMP | biological_process |
GO:0019048 | virus-host interaction | IEA | biological_process |
GO:0001934 | positive regulation of protein phosphorylation | TAS | biological_process |
GO:0010888 | negative regulation of lipid storage | IMP | biological_process |
GO:0045715 | negative regulation of low-density lipoprotein par | IMP | biological_process |
GO:0010745 | negative regulation of macrophage derived foam cel | IMP | biological_process |
GO:0007275 | multicellular organismal development | IEA | biological_process |
GO:0050900 | leukocyte migration | TAS | biological_process |
GO:0007160 | cell-matrix adhesion | IEA | biological_process |
GO:0045124 | regulation of bone resorption | TAS | biological_process |
GO:0030949 | positive regulation of vascular endothelial growth | TAS | biological_process |
GO:0005161 | platelet-derived growth factor receptor binding | TAS | molecular_function |
GO:0005886 | plasma membrane | IDA | cellular_component |
GO:0030168 | platelet activation | IMP | biological_process |
GO:0001938 | positive regulation of endothelial cell proliferat | IMP | biological_process |
GO:0010595 | positive regulation of endothelial cell migration | IMP | biological_process |
GO:0042060 | wound healing | IC | biological_process |
GO:0042802 | identical protein binding | IPI | molecular_function |
GO:0007596 | blood coagulation | TAS | biological_process |
GO:0032147 | activation of protein kinase activity | IMP | biological_process |
GO:0007155 | cell adhesion | TAS | biological_process |
GO:0007229 | integrin-mediated signaling pathway | TAS | biological_process |
GO:0002576 | platelet degranulation | TAS | biological_process |
GO:0060055 | angiogenesis involved in wound healing | TAS | biological_process |
GO:0042470 | melanosome | IDA | cellular_component |
GO:0071062 | alphav-beta3 integrin-vitronectin complex | TAS | cellular_component |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0035295 | tube development | TAS | biological_process |
GO:0007411 | axon guidance | TAS | biological_process |
GO:0006457 | protein folding | IDA | biological_process |
GO:0005887 | integral to plasma membrane | TAS | cellular_component |
GO:0003756 | protein disulfide isomerase activity | IDA | molecular_function |
GO:0050748 | negative regulation of lipoprotein metabolic proce | IMP | biological_process |
GO:0050839 | cell adhesion molecule binding | IPI | molecular_function |
GO:0070527 | platelet aggregation | IMP | biological_process |
GO:0004872 | receptor activity | IEA | molecular_function |
GO:0014909 | smooth muscle cell migration | IMP | biological_process |